Published: 11 November 2022

Ahead of the Autumn Statement, the Association of Medical Research Charities has joined a call for the Chancellor to place medical and health research at the heart of plans for growth.

The letter, signed by leading biomedical and health research institutions from the private and charitable sector including the Academy of Medical Sciences, Association of the British Pharmaceutical Industry, Wellcome, BioIndustry Association, Cancer Research UK, LifeArc and the British Heart Foundation, calls on the Chancellor to recommit to the plans laid out in the 2019 manifesto and maintain the 2021 Spending Review commitment to public R&D investment. 

It emphasises the critical role played by biomedical and health research in recovering from the COVID-19 pandemic and its importance of research to support the health and wealth of the UK now and in the future.

Nicola Perrin MBE, Chief Executive of the Association of Medical Research Charities said: ‚ÄúSustained long-term government research investment is essential for a diversity of funders including charities to build on and deliver patient benefits. We call on the government to maintain its commitment to stable funding to enable research to achieve impact for health and the economy."

You can view the letter and signatories here.